Phibro Animal Health CEO sells shares for taxes
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Daniel M Bendheim, President and CEO of Phibro Animal Health, reported the sale of 486 shares of Class A Common Stock at $36.599 per share on 2026-08-04. The disclosure states that these shares were sold in a broker-assisted cashless transaction to satisfy tax withholding upon the receipt of shares from vesting of restricted stock units, leaving him with 3,478 shares held directly afterward.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Class A Common Stock F1 | 486 | $36.599 | $18K |
Footnotes (1)
- F1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
Key Figures
Key Terms
broker assisted cashless exercise program financial
tax withholding obligations financial
restricted stock units financial
vesting and settlement financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Phibro Animal Health (PAHC) report for its CEO?
What type of security was involved in Daniel M Bendheim’s PAHC transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.